Table 2:

Observed perioperative mortality and annual adverse events for DAH in children in comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children

DAHRoss [18]Mechanical [10]Allograft [10]
Early death (%)0.944.197.3412.82
Late mortality (%/years)0.380.541.231.59
Reoperation and intervention (%/years)23.041.075.44
Structural valve degeneration (%/years)2.293.250.862.93
Thrombosis/bleeding (%/years)00.351.151.99
Endocarditis (%/years)0.290.270.450.66
DAHRoss [18]Mechanical [10]Allograft [10]
Early death (%)0.944.197.3412.82
Late mortality (%/years)0.380.541.231.59
Reoperation and intervention (%/years)23.041.075.44
Structural valve degeneration (%/years)2.293.250.862.93
Thrombosis/bleeding (%/years)00.351.151.99
Endocarditis (%/years)0.290.270.450.66

AVR: aortic valve replacement; DAH: decellularized aortic homografts.

Table 2:

Observed perioperative mortality and annual adverse events for DAH in children in comparison to reported results of paediatric Ross procedures, mechanical AVR and standard allograft implantation in children

DAHRoss [18]Mechanical [10]Allograft [10]
Early death (%)0.944.197.3412.82
Late mortality (%/years)0.380.541.231.59
Reoperation and intervention (%/years)23.041.075.44
Structural valve degeneration (%/years)2.293.250.862.93
Thrombosis/bleeding (%/years)00.351.151.99
Endocarditis (%/years)0.290.270.450.66
DAHRoss [18]Mechanical [10]Allograft [10]
Early death (%)0.944.197.3412.82
Late mortality (%/years)0.380.541.231.59
Reoperation and intervention (%/years)23.041.075.44
Structural valve degeneration (%/years)2.293.250.862.93
Thrombosis/bleeding (%/years)00.351.151.99
Endocarditis (%/years)0.290.270.450.66

AVR: aortic valve replacement; DAH: decellularized aortic homografts.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close